New Strategy for Prostate Cancer Prevention Based on Selenium Suppression of Androgen Receptor Signaling
Abstract
In this project, we investigated the potential of targeting the androgen receptor and the 5(alpha)-reductase simultaneously in prostate cancer prevention. We report that this combined androgen receptor blockade approach produced a synergistic effect on tumor growth inhibition by in vitro and in vivo. We have also identified that methylseleninic acid (MSA) activates FOXO1 and FOXO1 activation plays an important role in mediating apoptosis induction and androgen receptor suppression by MSA. In summary, the research support by this grant suggests a novel and effective approach for managing early stage prostate cancer and contributes to a better understanding of the anticancer effects of MSA.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 2010
- Accession Number
- ADA525643
Entities
People
- Haitao Zhang
Organizations
- Tulane University of Louisiana